TIPAL: The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole, a randomised placebo-controlled multi-centre clinical trial

 

TIPAL is  is an interventional clinical trial of an investigational medicinal product: a phase III, randomised, placebo-controlled, two arm parallel group, double-blind, multicentre clinical trial. (General summary/background?)

This study is funded by the National Institute for Health Research and Care Research (NIHR)

TIPAL is registered on the ISRCTN Trial Registry: ISRCTN13526307

 Follow the TIPAL trial on Twitter

Read more about the clinical trial